Abstract
We report a new β-thalassaemia allele detected in a young Italian woman, suffering with mild non-haemolytic anaemia (Hb < 10 g/dL) and not showing Hb variant or Heinz bodies. The allele is characterised by duplication of tetranucleotide ‘AG/CT’ (+1344/+1347) including the invariant dinucleotide ‘AG’ of IVS-II acceptor splicing site and the first two nucleotides of codon 105. β-Globin complementary DNA (cDNA) sequencing did not reveal any mutation and qualitative analysis of the reverse transcription PCR reaction showed that only the proximal 3′ splice site present in the duplicated gene is used giving race to an anomalous messenger RNA (mRNA) present in trace (1.5 %) because, most probably, rapidly degraded. In the anomalous mRNA, the insertion causes a frameshift and synthesis of an abnormal truncated β-chain (139 residues), unable to form Hb variant because of the severe conformational changes. The duplication might have arisen from secondary structures generated by quasi-palindromic sequence 5′-CCCA(C)AG/CT(CC)TGGG-3′. Restriction fragment length polymorphism analysis for the β-globin haplotype and familiar segregation analysis indicated that the mutant β-globin gene was associated with the haplotype V.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Giardine B, van Baal S, Kaimakis P et al (2007) HbVar database of human hemoglobin variants and Thalassemia mutations: 2007 update. Hum Mutat 28(2):206
Jain PK, Dozy AM, Verma IC, Chehab FF (1994) A new frameshift mutation, insertion of ATCT, at codon 48 in the beta-globin gene causes beta-thalassemia in an Indian proband. Hum Mutat 3(4):397–398
Frischknecht H, Kiewitz R, Schmugge M (2005) A 4 base pair TGAT insertion at codon 116 of the beta globin gene causes beta0-thalassemia. Haematologica 90(Suppl):ECR20
Flatz G, Wilke K, Syagailo YV et al (1999) Beta-thalassemia in the German population: mediterranean, Asian and novel mutations. Mutations in brief no.228. Online. Hum Mutat 13(3):258
Thein SL (1992) Dominant beta thalassaemia: molecular basis and pathophysiology. Br J Haematol 80(3):273–277
Rojnuckarin P, Settapiboon R, Vanichsetaku P et al (2007) Severe beta(0) thalassemia/hemoglobin E disease caused by de novo 22-base pair duplication in the paternal allele of beta globin gene. Am J Hematol 82(7):663–665
Svasti S, Boonchoy C, Vanichsetakul P, Winichagoon P, Fucharoen S (2008) Molecular mechanism of beta-thalassaemia caused by 22-bp duplication. Ann Hematol 87(8):633–637
Pagano L, Lacerra G, Camardella L et al (1991) Hemoglobin Neapolis, beta 126(H4)Val→Gly: a novel beta-chain variant associated with a mild beta-thalassemia phenotype and displaying anomalous stability features. Blood 78(11):3070–3075
Lacerra G, Musollino G, Scarano C et al (2008) Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area. Gene 410(1):129–138
Losekoot M, Fodde R, Harteveld CL et al (1990) Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia. Br J Haematol 76(2):269–274
Bowden DK, Vickers MA, Higgs DR (1992) A PCR-based strategy to detect the common severe determinants of alpha thalassaemia. Br J Haematol 81(1):104–108
Dode C, Krishnamoorthy R, Lamb J, Rochette J (1993) Rapid analysis of -alpha 3.7 thalassaemia and alpha alpha alpha anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 83(1):105–111
Lacerra G, Musollino G, Di Noce F et al (2007) Genotyping for known Mediterranean alpha-thalassemia point mutations using a multiplex amplification refractory mutation system. Haematologica 92(2):254–255
Lacerra G, Testa R, De Angioletti M et al (2003) Hb Bronte or alpha 93(FG5)Val→Gly: a new unstable variant of the alpha 2-globin gene, associated with a mild alpha(+)-thalassemia phenotype. Hemoglobin 27(3):149–159
De Angioletti M, Lacerra G, Sabato V, Carestia C (2004) Beta + 45G→C: a novel silent beta-thalassaemia mutation, the first in the Kozak sequence. Br J Haematol 124(2):224–231
Luukkonen B, Seraphin B (1997) The role of branchpoint-3′ splice site spacing and interaction between intron terminal nucleotides in 3′ splice site selection in Saccharomyces cerevisiae. Embo J 16(4):779–792
Lahr G, Brintrup J, Over S et al (2007) Codon 104(-G), a dominant beta0-thalassemia-like phenotype in a German Caucasian family is associated with mild chronic hemolytic anemia but influenced in severity by co-inherited genetic factors. Haematologica 92(9):1264–1265
Bibi A, Messaoud T, Beldjord C, Fattoum S (2006) Detection of two rare beta-thalassemia alleles found in the Tunisian population: codon 47 (+A) and codons 106/107 (+G). Hemoglobin 30(4):437–447
Hopmeier P, Krugluger W, Gu LH et al (1996) A newly discovered frameshift at codons 120–121 (+A) of the beta gene is not associated with a dominant form of beta-thalassemia. Blood 87(12):5393–5394
Hall GW, Thein S (1994) Nonsense codon mutations in the terminal exon of the beta-globin gene are not associated with a reduction in beta-mRNA accumulation: a mechanism for the phenotype of dominant beta-thalassemia. Blood 83(8):2031–2037
Fasken MB, Corbett AH (2009) Mechanisms of nuclear mRNA quality control. RNA Biol 6(3):237–241
Acknowledgments
We acknowledge the Patient and the family for the collaboration. This study was supported by Ministero Istruzione, Università e Ricerca (MIUR), Legge 488/92, Cluster C02, Project 2.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is dedicated to the memory of Clementina Carestia.
Rights and permissions
About this article
Cite this article
Musollino, G., Mastrolonardo, G., Prezioso, R. et al. Molecular mechanisms of a novel β-thalassaemia mutation due to the duplication of tetranucleotide ‘AGCT’ at the junction IVS-II/exon 3. Ann Hematol 91, 1695–1701 (2012). https://doi.org/10.1007/s00277-012-1526-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-012-1526-y